Febrile neutropenia in the tropics: A description of clinical and microbiological findings and their impact on inappropriate therapy currently used at an oncological reference center in Colombia

Biomedica

Volumn 33, Issue 1, 2013, Pages 70-77

  Cortés, Jorge A ^a   Cuervo, Sonia ^a,b   Gómez, Carlos A ^a   Bermúdez, Diana ^b   Martínez, Teresa ^b   Arroyo, Patricia ^b  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Instituto Nacional de Cancerología   (Colombia)

Author keywords

Antineoplastic agents adverse events; Colombia; Neoplasm complications; Neutropenia microbiology; Neutropenia mortality

Indexed keywords

EID: 84884360295     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:427-31. http://dx.doi.org/10.1093/cid/ciq147
2. Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: Epidemiology, microbiology, and risk stratification. Clin Infect Dis. 2005;40(Suppl.4):S240-5. http://dx.doi.org/10.1086/427329
3. Rolston KV. Challenges in the treatment of infections caused by Gram-positive and Gram-negative bacteria in patients with cancer and neutropenia. Clin Infect Dis.2005;40(Suppl.4):S246-52.http://dx.doi.org/10.1086/427331
4. Viscoli C. The evolution of the empirical management of fever and neutropenia in cancer patients. J Antimicrob Chemother.1998;41(Suppl.D):65-80.http://dx.doi.org/10.1093/jac/41.suppl_ 4.65
5. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria. Clin Infect Dis. 1999;29:490-4. http://dx.doi.org/10.1086/598620
6. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36:1103-10. http://dx.doi.org/10.1086/374339
7. Oppenheim BA. The changing pattern of infection in neutropenic patients. J Antimicrob Chemother. 1998;41 (Suppl.D):7-11. http://dx.doi.org/10.1093/jac/41.suppl_4.7
8. Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005;353:977-87.
9. Figuera M, Carballo M, Silva M, Figueredo A, Avilan J. Microbiological isolates in patients with febrile neutropenia and hematological neoplasias. Rev Esp Quimioter. 2006;19:47-51.
10. Rabagliati BR, Fuentes LG, Orellana UE, Oporto CJ, Domínguez MI, Benítez GR, et al. Etiología de episodios de neutropenia febril en pacientes adultos con cáncer hematológico y de órganos sólidos en el Hospital Clínico Universidad Católica, Santiago-Chile. Rev Chilena Infectol. 2009;26:106-13. http://dx.doi.org/10.4067/S0716-10182009000200001
11. Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, et al. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect. 2010;138:1044-51. http://dx.doi.org/10.1017/S0950268809991208
12. Cardona AF, Combariza JF, Reveiz L, Ospina EG, Poveda CM, Ruiz CA, et al. Clinical and microbiological characteristics of neutropenic enterocolitis in adults with blood cancer in the National Cancer Institute of Bogota D.C. (Colombia). Enferm Infecc Microbiol Clin. 2004;22:462-6.
13. Botero JH, Castaño A, Montoya MN, Ocampo NE, Hurtado MI, Lopera MM. A preliminary study of the prevalence of intestinal parasites in immunocompromised patients with and without gastrointestinal manifestations. Rev Inst Med Trop Sao Paulo. 2003;45:197-200. http://dx.doi.org/10.1590/S0036-46652003000400004
14. Siu LK, Lu PL, Hsueh PR, Lin FM, Chang SC, Luh KT, et al. Bacteremia due to extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in apediatric oncology ward: Clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol. 1999;37:4020-7.
15. Palasubramaniam S, Subramaniam G, Muniandy S, Parasakthi N. SHV-5 extended-spectrum beta-lactamase from Klebsiella pneumoniae associated with a nosocomial outbreak in a paediatric oncology unit in Malaysia. Int J Infect Dis. 2005;9:170-2. http://dx.doi.org/10.1016/j.ijid.2004.07.005
16. Briceño DF, Correa A, Valencia C, Torres JA, Pacheco R, Montealegre MC, et al. Actualización de la resistencia a antimicrobianos de bacilos Gram negativos aislados en hospitales de nivel III: años 2006, 2007, 2008. Biomédica. 2010;30:371-81.
17. Cometta A, Calandra T, Bille J, Glauser MP. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med. 1994;330:1240-1.
18. Gómez L, Garau J, Estrada C, Márquez M, Dalmau D, Xercavins M, et al. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. Cancer. 2003;97:419-24. http://dx.doi.org/10.1002/cncr.11044
19. Rolston KV, Yadegarynia D, Kontoyiannis DP, Raad, II, Ho DH. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients. Int J Infect Dis. 2006;10:223-30. http://dx.doi.org/10.1016/j.ijid.2005.05.007
20. Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis. 2000; 19: 915-25. http://dx.doi.org/10.1007/s100960000410
21. Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, et al. A multi-centre prospective study of febrile neutropenia in Norway: Microbiological findings and antimicrobial susceptibility. Scand J Infect Dis. 2005;37:455-64.
22. Giamarellos-Bourboulis EJ, Papadimitriou E, Galanakis N, Antonopoulou A, Tsaganos T, Kanellakopoulou K, et al. Multidrug resistance to antimicrobials as a predominant factor influencing patient survival. Int J Antimicrob Agents. 2006;27:476-81.http://dx.doi.org/10.1016/j.ijantimicag.2005.12.013,